Codelivery of 1α,25-Dihydroxyvitamin D3 and CYP24A1 Inhibitor VID400 by Nanofiber Dressings Promotes Endogenous Antimicrobial Peptide LL-37 Induction.
Saved in:
| Title: | Codelivery of 1α,25-Dihydroxyvitamin D |
|---|---|
| Authors: | Su Y; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States., Ganguli-Indra G; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States., Bhattacharya N; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States., Logan IE; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States., Indra AK; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.; Department of Dermatology, Oregon Health & Science University, Portland, Oregon 97239, United States., Gombart AF; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States., Wong SL; Department of Surgery-Plastic Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States., Xie J; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.; Department of Mechanical and Materials Engineering, College of Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States. |
| Source: | Molecular pharmaceutics [Mol Pharm] 2022 Mar 07; Vol. 19 (3), pp. 974-984. Date of Electronic Publication: 2022 Feb 18. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101197791 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1543-8392 (Electronic) Linking ISSN: 15438384 NLM ISO Abbreviation: Mol Pharm Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35179903 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Codelivery of 1α,25-Dihydroxyvitamin D<subscript>3</subscript> and CYP24A1 Inhibitor VID400 by Nanofiber Dressings Promotes Endogenous Antimicrobial Peptide LL-37 Induction. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Su+Y%22">Su Y</searchLink>; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.<br /><searchLink fieldCode="AU" term="%22Ganguli-Indra+G%22">Ganguli-Indra G</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.<br /><searchLink fieldCode="AU" term="%22Bhattacharya+N%22">Bhattacharya N</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.<br /><searchLink fieldCode="AU" term="%22Logan+IE%22">Logan IE</searchLink>; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.<br /><searchLink fieldCode="AU" term="%22Indra+AK%22">Indra AK</searchLink>; Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Corvallis, Oregon 97331, United States.; Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon 97239, United States.; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.; Department of Dermatology, Oregon Health & Science University, Portland, Oregon 97239, United States.<br /><searchLink fieldCode="AU" term="%22Gombart+AF%22">Gombart AF</searchLink>; Linus Pauling Institute, Department of Biochemistry and Biophysics, Oregon State University, Corvallis, Oregon 97331, United States.<br /><searchLink fieldCode="AU" term="%22Wong+SL%22">Wong SL</searchLink>; Department of Surgery-Plastic Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.<br /><searchLink fieldCode="AU" term="%22Xie+J%22">Xie J</searchLink>; Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, Nebraska 68198, United States.; Department of Mechanical and Materials Engineering, College of Engineering, University of Nebraska-Lincoln, Lincoln, Nebraska 68588, United States. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101197791%22">Molecular pharmaceutics</searchLink> [Mol Pharm] 2022 Mar 07; Vol. 19 (3), pp. 974-984. <i>Date of Electronic Publication: </i>2022 Feb 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101197791 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-8392 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215438384%22">15438384 </searchLink><i>NLM ISO Abbreviation: </i>Mol Pharm <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35179903 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.molpharmaceut.1c00944 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 974 Titles: – TitleFull: Codelivery of 1α,25-Dihydroxyvitamin D3 and CYP24A1 Inhibitor VID400 by Nanofiber Dressings Promotes Endogenous Antimicrobial Peptide LL-37 Induction. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Su Y – PersonEntity: Name: NameFull: Ganguli-Indra G – PersonEntity: Name: NameFull: Bhattacharya N – PersonEntity: Name: NameFull: Logan IE – PersonEntity: Name: NameFull: Indra AK – PersonEntity: Name: NameFull: Gombart AF – PersonEntity: Name: NameFull: Wong SL – PersonEntity: Name: NameFull: Xie J IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 03 Text: 2022 Mar 07 Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1543-8392 Numbering: – Type: volume Value: 19 – Type: issue Value: 3 Titles: – TitleFull: Molecular pharmaceutics Type: main |
| ResultId | 1 |
